In one paragraphArticle in Pediatric blood & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Angela LiouDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.ORCID 0000-0002-3609-0373 John Van ArnamDepartment of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Vinodh PillaiDepartment of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Alix E SeifDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.ORCID 0000-0002-1799-2582 Sarah K TasianDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.ORCID 0000-0003-1327-1662 Charles A PhillipsDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.ORCID 0000-0002-0391-1673 Funding
Postdoctoral Training Program in Genomic MedicineT32HG009495 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI Katherine L. Nathanson, Bogdan Pasaniuc · 2017 to 2026
$4.2MMultispecific targeting incorporating cytokine receptor pathways in high risk pediatric acute leukemias to improve durability of adoptive cell therapy-induced remissionsU01CA232486 · NCI · UNIVERSITY OF COLORADO DENVER · PI FRY, TERRY J., TASIAN, SARAH KATHLEEN · 2018 to 2018
$4.0MPI3K Pathway Inhibition for Philadelphia-Like Acute Lymphoblastic LeukemiaK08CA184418 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI TASIAN, SARAH KATHLEEN · 2014 to 2018
$848kNCI NIH HHS K08 CA184418NCI NIH HHS K08CA184418NCI NIH HHS U01 CA232486NHGRI NIH HHS T32 HG009495
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Hematopoietic Stem Cell TransplantationHumansInfant, NewbornLeukocytosisLymphocyte DepletionMaleMonocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisReceptors, Antigen, T-Cell, alpha-betaT-LymphocytesTransplantation, HaploidenticalReceptors, Antigen, T-Cell, alpha-beta
Identifiers
PMID31867817
PMCPMC7721203
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390